Clinical Trial Update: A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With Infantile Fibrosarcoma (IFS), a Type of Connective Soft Tissue Cancer, Who Received a Treatment Called Larotrectinib From a Study Called SCOUT With Patient Data From an External Database

View source ↗

Summary

A clinical trial update for EPI VITRAKVI comparing treatment results in infantile fibrosarcoma patients who received larotrectinib in the SCOUT study with exter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Fibrosarcoma

Drugs mentioned

• Larotrectinib (larotrectinib)

Snippet

Sponsor: Bayer | Conditions: Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion, Infantile Fibrosarcoma | Status: COMPLETED | Results posted: 2024-12-10